LOA has provided consulting services to over 23 organizations — from early-stage Israeli startups to global Big Pharma. Most clients have been referred through past interactions or word of mouth.
Early-stage companies developing innovative oncology assets who need scientific and strategic guidance to navigate drug development and attract investment.
Growing companies seeking experienced oncology expertise in clinical development, regulatory strategy, or business development at critical inflection points.
Large pharmaceutical companies and VCs requiring oncology expertise for due diligence, licensing evaluation, M&A support, or scientific advisory roles.